A simple strategy could make first-line antibiotics more effective against resistant bacteria
Researchers have identified a single, simple metric to inform medication regimen design that could bring an entire arsenal of first-line antibiotics back into the fight against drug-resistant pathogens.
A computer simulation created by Hannah Meredith, a biomedical engineering graduate fellow at Duke University, revealed that a regimen based on a pathogen’s recovery time could eliminate an otherwise resistant strain of bacteria. In theory, a database of recovery times for bacterial and antibiotic combinations could allow first-line antibiotics to clear many resistant infections.
Meredith has already begun lab work to create such a database, and early tests are confirming her model’s predictions.
The study appears in PLOS Computational Biology on April 23, 2015.
“Bacteria are forming resistance to antibiotics faster than we can make new ones, so there is a real need to use the antibiotics that are already on the market more efficiently,” said Meredith. “We hope this research will help hospitals improve patient outcomes while also making our antibiotics last as long as possible.”
The computer simulation models the relationship between bacteria, antibiotics and a method of resistance called beta-lactamase—an enzyme that degrades beta-lactam antibiotics, one of the largest and most-used classes of antibiotics. Many beta-lactam antibiotics are currently disregarded out of concern for the infection being completely resistant to that type of antibiotic—even if the antibiotic appeared to be effective in the lab. The new model, however, reveals that the infection might be temporarily sensitive to the antibiotic before the beta-lactamase degrades the drug and allows the infection to recover.
“You can think of this as a race between the cells and the antibiotics,” said Lingchong You, the Paul Ruffin Scarborough Associate Professor of Biomedical Engineering at Duke and Meredith’s advisor. “Before their beta-lactamase degrades the antibiotics, the cells are still sensitive and can be killed. But the antibiotics degrade faster than the cell population declines, allowing some cells to survive and repopulate.”
When clinicians realize an infection is resistant, they often skip straight to some of the strongest antibiotics available. But the study indicates that if they instead changed the dosing frequency of first-line antibiotics such that each dose is delivered while the bacteria are weakened during their recovery period, some infections could be cleared without skipping to the last resort.
Doctors also need to be careful, however, not to wreck native populations of bacteria vital to human health. A database detailing the responses of different strains to different antibiotics could allow Meredith’s computer model to determine the most efficient regimen to keep total exposure to a minimum. It could also indicate if multiple doses would not work, letting clinicians know when it is time to call in the heavy artillery.
Read more: Finding New Life for First-Line Antibiotics
The Latest on: Antibiotics
via Google News
The Latest on: Antibiotics
- Use of antibiotics for COVID-19 will cause more deaths ― WHOon June 1, 2020 at 3:03 pm
WHO warns increased antibiotics use in combating the COVID-19 pandemic will strengthen bacterial resistance and ultimately lead to more deaths ...
- WHO warns overuse of antibiotics for Covid-19 will cause more deathson June 1, 2020 at 2:55 pm
Director general says “worrying number” of bacteria are becoming resistant to medicines ...
- Antibiotics will not to be given for sepsis, trust sayson June 1, 2020 at 2:26 pm
Samantha Brousas, 49, from Gresford, died in 2018 after waiting for three hours outside hospital in a Welsh Ambulance Service Trust (WAST) vehicle. Following the inquest, coroner Joanne Lees wrote to ...
- Pandemic antibiotics surge will cause more deaths: WHOon June 1, 2020 at 1:57 pm
Increased antibiotics use in combating the COVID-19 pandemic will strengthen bacterial resistance and ultimately lead to more deaths during the crisis and beyond, the World Health Organization said ...
- Postcolonoscopy Antibiotics Linked With IBSon June 1, 2020 at 11:33 am
Antibiotic exposure after screening colonoscopy could increase the risk for irritable bowel syndrome (IBS), a retrospective analysis of more than 400,000 people shows ...
- Antibiotics Market Competitive Research and Analysis 2020 to 2025on June 1, 2020 at 5:04 am
This Global Antibiotics Market Research Report Forecast 2020-2025 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and ...
- Group B strep and having a baby: what pregnant women need to knowon May 29, 2020 at 5:13 am
Group B streptococcal (GBS) is a common bacteria that likes to live in the human gut and migrate down the rectum, vagina and sometimes to the urinary tract. Not everyone has GBS but even if you do, ...
- Fear not: The milk you drink contains no antibioticson May 26, 2020 at 10:01 pm
We just celebrated National Chocolate Chip Day, and I think we all know that the best way to eat a chocolate chip cookie is with an ice-cold glass of milk.
- US farms are using MORE antibiotics despite warnings that overuse will spread superbugson May 23, 2020 at 3:03 pm
Figures obtained by The Mail on Sunday reveal that the sale of antibiotics to American farms jumped from 5,559 tons in 2017 to 6,036 tons in 2018 - a 9 per cent rise (file photo).
- Insight into mechanism of treatment-resistant gonorrhea sets stage for new antibioticson May 22, 2020 at 9:10 am
Medical University of South Carolina researchers investigated the effects of mutations altering the structure of an essential protein in an antibiotic-resistant strain of Neisseria gonorrhoeae. They ...
via Bing News